Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of Platelet Function and Inhibition in Patients Recovering from Severe Infection
2016-004303-32Phase 4Terminated
- Sponsor
- VU university medical center
- Start
- Apr 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aspirin in Platelet hyperaggregability, sponsored by VU university medical center. Primary endpoint: PFA-200 parameters. Started Apr 2017; status: terminated.
02
Drugs
aspirin
03
Conditions
Platelet hyperaggregability
Beyond the preview
Go deeper on 2016-004303-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004303-32.